BCR and cancer: Other prognostic models, including histological data, have been developed to predict BCR or metastasis-free survival (MFS), such as the Kattan nomogram [8], the cancer of the prostate risk assessment (CAPRA) score [9], and the STAR-CAP prognostic system [10].